Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acute, attained, attainment, Australia, Batten, bearing, BPCIA, Brazilian, brian, bring, CA, Carlo, Center, ceroid, CMS, Cork, cybersecurity, dispensing, district, duration, enhanced, enterprise, ETASU, forfeiture, Greece, Greek, Hatch, hematologic, hematological, inadequacy, induction, infantile, infrastructure, input, IP, Irish, Italy, lattice, leukemia, lifted, LINCL, Lindaro, lymphocytic, lymphoma, mantle, matter, methodology, misappropriation, Monte, mueller, multiplied, multiplier, Myasthenia, myelodsplastic, myeloid, Network, neuronal, outlicense, Pathology, peer, percentile, Pfizer, Portugal, pose, preset, problem, qualitative, Quantitative, quickest, Rafael, ranking, ratably, Real, relocate, repayment, requalify, resource, RSU, sabotage, safest, score, Shanbally, shareholder, simulation, slightly, software, Southern, sovereign, Spain, SR, standby, stay, sulfatase, theft, training, TSR, uncollectable, upheld, urinary, velocity, Waxman, withheld, withholding
Filing tables
Filing exhibits
- 10-K Annual report
- 3.3 Certificate of Amendment to Amended and Restated Certificate of Incorporation
- 10.25 Asset Purchase Agreement
- 10.34 Lease Agreement - 770 Lindaro Street
- 10.35 Lease Agreement - 790 Lindaro Street
- 21.1 Subsidiaries of Biomarin Pharmaceutical Inc.
- 23.1 Consent of KPMG LLP
- 23.2 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A)/15D-14(A)
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A)/15D-14(A)
- 32.1 Certification of CEO and CFO Pursuant to Section 906
- 99.1 Biomarin/genzyme LLC Consolidated Financial Statements
Related press release
BMRN similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries of BioMarin Pharmaceutical Inc. as of December 31, 2011
Name | Direct Parent(s) | Ownership | Jurisdiction of Incorporation | |||
Huxley Pharmaceuticals Ltd. | BioMarin Pharmaceutical Inc. | 100% | Ireland | |||
BioMarin GALNs Ltd. | BioMarin Pharmaceutical Inc. | 100% | Ireland | |||
BMRN 701 Limited | BioMarin Pharmaceutical Inc. | 100% | Ireland | |||
BioMarin Brasil Farmaceutica Ltda. | BioMarin Pharmaceutical Inc. | 100% | Brazil | |||
BioMarin Holding Limited | BioMarin Pharmaceutical Inc. | 100% | Ireland | |||
BioMarin Holdings (LUX) S.A.R.L. | BioMarin Holding Limited | 100% | Luxembourg | |||
BioMarin Europe Ltd. | BioMarin Holdings (LUX) S.A.R.L. | 100% | Ireland |